Latest stocks in the news

V.F. Corp (VFC) is experiencing a continued boost in its stock value, surging by 13% following a recent rebound from its 52-week lows. This positive momentum is attributed to a report from The Wall Street Journal, which revealed that Engaged Capital is increasing its stake in the renowned apparel and footwear company, recognized for brands like The North Face and Vans. Engaged Capital's move to acquire shares at this juncture is due to their confidence in implementing proposed changes that could rejuvenate VFC. Among the initiatives mentioned in the WSJ report are cost-saving measures that could potentially yield over $300 million annually and an exploration of a strategic review of VFC's noncore assets and real estate. Reviving VFC, despite its global brand recognition, is anticipated to be a challenging endeavor, especially in the short term. The retail sales data for September suggested consumers' willingness to continue spending, but apparel and footwear brands have been facing difficulties in the current economic climate. In August, VFC's management acknowledged the complexity and volatility of macroeconomic conditions, particularly with the end of the student loan pause in sight. Nonetheless, VFC remains optimistic about boosting operating earnings through improved gross margins and robust cash flow, even if they exercise caution concerning top-line growth in the near future. Their ongoing cost-saving efforts involve the implementation of enhanced automation in their facilities and an improved digital consumer interface. The direct-to-consumer sales approach showed early success in the previous quarter, demonstrating the efficacy of this strategic shift. With a new CEO at the helm since the retirement of the former executive Steven Rendle in December, VFC is already on its path to recovery. CEO Bracken Darrell, who took over earlier this year, has demonstrated a track record of leading corporate turnarounds, notably expanding Logitech's market share and revenue during his tenure as CEO of LOGI. This transition in leadership is one of the reasons Engaged Capital is optimistic about reversing VFC's streak of underwhelming earnings reports. In summary, Engaged Capital's increasing stake in VFC is a vote of confidence in the company, its iconic brands, and the ability of the new CEO to replicate his successful strategies at LOGI. While the backdrop of retail demand faces challenges due to softening consumer spending in the wake of higher interest rates and persistent inflation, VFC retains brand loyalty and a promising long-term outlook. The sustained interest in outdoor activities since the pandemic, such as travel and camping, aligns well with VFC's emphasis on outdoor footwear and apparel.

Wyndham Hotels & Resorts (WH) has experienced a significant increase in its stock value, rising by 9%, following the recent announcement by Choice Hotels (CHH) of a proposed acquisition at $90 per share in cash and stock. Remarkably, these discussions have been ongoing since April, with Choice making several proposals, improving the offer price and increasing the cash component. However, Wyndham has expressed concerns about the value of Choice's stock and the timing of regulatory approvals, leading to its reluctance to engage in further negotiations. Choice's decision to make the bid public may be an attempt to garner support from WH shareholders and put pressure on WH management. From our perspective, it's evident why Choice finds Wyndham an attractive prospect. WH is the world's largest hotel franchising company in terms of the number of properties and holds a dominant position in the economy and midscale segments of the lodging industry. It manages a portfolio of 24 hotel brands, including Super 8, Days Inn, Ramada, Microtel, and La Quinta. WH has transformed into a pure-play franchise business by divesting its own hotels and exiting the US Hotel Management sector. While Choice is not as large as Wyndham, it is a substantial lodging franchisor with 22 brands covering upper upscale, midscale, extended stay, and economy properties. While a merger seems financially logical, questions arise about whether it would pass regulatory scrutiny. Additionally, WH appears less enthusiastic about Choice's substantial equity offerings. Choice's latest $90 proposal includes $49.50 in cash and 0.324 shares of CHH, maintaining a 55/45 split. WH has also raised concerns about the value of Choice's stock, indicating a preference for a higher cash component. Another important aspect is that WH's business has been in recovery mode, with strong Q2 results reported in late July. The company noted robust demand growth and overseas recovery, particularly in China, which has reached 99% of 2019 RevPAR levels. The stock has pulled back recently, and it's likely that WH's management is cautious about selling at this point, especially with increased travel activity and the upcoming infrastructure opportunities in mind.

Bank of America (BAC) has reported robust third-quarter 2023 results, echoing the positive outcomes of JPMorgan Chase (JPM), Wells Fargo (WFC), and Citigroup (C). The bank's success is attributed to healthy growth in net interest income and a resurgence in its investment banking and trading sectors. Rising interest rates have notably benefited BAC, enabling it to generate a wider spread between interest earnings from loans and the interest paid on deposits and savings accounts. The bank's trading business, particularly in fixed income, experienced a 6% growth in trading revenue, totaling $2.7 billion, largely fueled by strength in mortgage products and solid equity trading activity, leading to a 10% increase in trading fees, reaching $1.7 billion. BAC, like its counterparts in the banking industry, also saw a revival in its investment banking activities. Global banking revenue surged by 6% to $10.5 billion, driven by increased fees related to mergers and acquisitions. Investment banking fees rose by 2%, with BAC securing the third position in the industry for investment banking fees. On the consumer banking front, BAC achieved a 6% growth in revenue, reaching $10.5 billion, driven by higher net interest income and loan balances. However, deposits decreased by 8% due to intensified competition for deposits in the current environment of rising interest rates. Despite the strong performance, BAC's earnings report did reveal a few concerns. Net charge-offs increased by nearly $400 million year-on-year, reaching $911 million, reflecting the impact of higher interest rates on credit cards. While still below pre-pandemic levels, net charge-offs will be a metric to monitor as consumers manage their credit card bills. Furthermore, BAC saw a spike in unrealized losses on its "held-to-maturity" instruments, primarily government debt and mortgage-backed securities, totaling $131.6 billion as interest rates rose. Although BAC is not obliged to recognize these losses, they are constraining the amount of capital available for lending. Overall, Bank of America's performance was commendable considering the challenging macroeconomic conditions, with U.S. consumer spending showing signs of slowing, albeit remaining ahead of the previous year, according to CEO Brian Moynihan.

Goldman Sachs (GS) is trading slightly lower following the release of its Q3 results. This comes as a rebound from an EPS miss in Q2, with the recent report showing modest upside. While the bank experienced a 1.3% year-on-year decrease in revenues, totaling $11.82 billion, this figure surpassed analyst expectations. Notably, Goldman recently announced a deal to sell its GreenSky platform and associated loan assets, signaling a shift away from consumer lending and a renewed focus on its core franchises: Global Banking & Markets (GBM) and Asset & Wealth Management (AWM). Within the Q3 report, the GBM segment stood out as the largest for Goldman, with a 6% year-on-year and 11% sequential increase in revenue to $8.01 billion. While Investment Banking fees overall rose by only 1% to $1.55 billion, Equity and Debt underwriting units performed well, rising by 26% and 27%, respectively. Goldman's involvement in notable IPOs like ARM and CART in September fueled growth in equity and debt underwriting. However, a 15% drop in advisory fees due to a decline in completed M&A transactions limited the growth of its IB subsegment. During the earnings call, Goldman mentioned the reopening of the IPO market since Labor Day and its role as a lead or joint bank in several IPOs, highlighting the potential for a wider reopening of capital markets. If favorable conditions persist, Goldman anticipates a recovery in capital markets and strategic activity. As a leader in M&A advisory and equity underwriting, such a resurgence could provide a positive momentum. Within the GBM segment, the FICC unit reported a 6% year-on-year revenue decline to $3.38 billion, partially attributed to challenging comparisons with a strong Q3 2022. Equities subsegment revenues increased by 8% to $2.96 billion, mainly due to higher revenue in prime financing, offset by lower revenue from portfolio financing. Meanwhile, the AWM segment saw a 20% year-on-year revenue decline to $3.23 billion, driven by net losses in Equity investments, partially offset by higher Management and other fees. In terms of the macroeconomic outlook, the US economy has displayed resilience, although vigilance remains necessary. Treasury rates have risen notably over recent months, and data indicating higher-than-expected inflation and employment figures have contributed to expectations of prolonged higher interest rates. Overall, the market's response to Goldman's report has been somewhat muted, reflecting a mix of factors. While there were positive aspects, such as exceeding consensus estimates and strong underwriting performance, there were also areas of weakness, including a struggling FICC business and revenue decline in the AWM segment. Additionally, macroeconomic concerns persist. Nevertheless, Goldman's decision to divest from its consumer business, particularly GreenSky, has been positively received.

Johnson & Johnson (JNJ) has posted healthy third-quarter results, marked by double-digit earnings surpassing expectations and solid revenue growth, excluding its former Consumer Health business, which was spun off into Kenvue (KVUE) in May. The quarter represents the first for the leaner JNJ, which delivered strong numbers, yet the market reaction was less enthusiastic. This response reflects a level of disappointment that the results weren't more substantial and lingering uncertainties on the horizon. Revenue, excluding Consumer Health, increased by 6.8% year-on-year, reaching $21.35 billion, slightly higher than anticipated, contributing to a 19.3% increase in earnings – the fourth consecutive double-digit beat. The growth driver for JNJ continues to be its MedTech division, which expanded by 10.0% year-on-year, driven in part by the $16.6 billion acquisition of Abiomed last year. However, the MedTech segment faced challenges during the quarter due to international sanctions in Russia, volume-based procurement in China, and seasonal variations in surgical procedures. Despite these headwinds, JNJ's MedTech margins fell in Q3, primarily due to commodity inflation and an unfavorable product mix. The company is in the process of implementing a two-year restructuring program to enhance MedTech's margin profile, with an expected revenue disruption of around $250 million to be completed by 2025. JNJ's Innovative Medicine segment, formerly its Pharmaceutical division, experienced sales growth of 5.1% to $13.89 billion. However, the overseas performance lagged due to the loss of exclusivity for Zytiga in Europe, causing a 2.3% sales decline internationally while domestic sales improved by 10.9%. Margins in the Innovative Medicine segment showed significant improvement, rising by 400 basis points year-on-year to 45.4%. Despite the solid Q3 performance, JNJ's stock has faced a roughly 10% correction since its August highs, and ongoing talc litigation remains a source of concern. The company has reiterated its four-pronged strategy to address this issue. Additionally, the impact of new weight-loss medicines (GLP-1s) on its bariatric business in the short term has raised concerns. Nonetheless, JNJ is optimistic that GLP-1s could eventually act as a positive factor, complementing potential surgical procedures. While challenges persist, the Q3 results present an encouraging outlook, making the recent sell-off an attractive entry point, especially in light of healthcare's defensive nature in uncertain economic conditions.

Previous update:

Vista Outdoor (VSTO) faced a significant decline in its stock price following its decision to sell its Sporting Products segment to Czechoslovak Group a.s. in an all-cash deal valued at $1.91 billion. The transaction, anticipated to be finalized in 2024, was priced at approximately 5 times the Sporting Products segment's EBITDA for FY24. In addition to this, VSTO revised its FY24 (ending in March) adjusted earnings and revenue forecasts downward, attributing the changes to challenging economic conditions exacerbated by prolonged high interest rates. The company now targets sales of $2.725-2.825 billion and adjusted EPS of $3.65-4.05, down from previous estimates of $2.85-2.95 billion and $4.50-5.00, respectively. Vista Outdoor has been undergoing a restructuring process for over a year, with plans to separate its Outdoor Products and Sporting Products segments into two distinct, publicly traded entities, announced in May 2022. This announcement initiated a prolonged period of declining share prices, resulting in a roughly 35% decrease. Despite aligning with VSTO's strategy to split into two separate organizations, the recent deal, valued at 5 times FY24 EBITDA and slightly above 1 times FY24 sales, did not meet investors' expectations, which is partially reflected in the current sell-off. Moreover, VSTO has faced macroeconomic challenges for much of the past year. However, last quarter's comments from management suggested demand stabilization in the Sporting Products segment as the market normalized. VSTO indicated that with a normalized market, it expected to return to regular purchasing patterns and maintain consistent demand for various Sporting Products in the future. Despite these optimistic remarks, the downward revision in guidance today came as a disappointment. Both of VSTO's segments are grappling with more substantial challenges than initially anticipated, with projections indicating lower sales in the Sporting Products and a notable drop in Outdoor Products compared to previous estimates. VSTO's decision to divest its Sporting Products business and the lowered FY24 guidance has impacted its stock negatively. While the persistent adverse economic environment has been a burden this year, given the strong brand loyalty associated with the various labels under the Sporting Products business, investors may have preferred a higher selling price or even the retention of this segment, spun off as a publicly-listed company, much like VSTO's plan for its Outdoor Products division.

Lululemon Athletica (LULU) is enjoying a significant boost in its stock price, surging by 10%, thanks to the news of its inclusion in the S&P 500, effective prior to the opening of the market on Wednesday. This achievement is a noteworthy milestone for the yoga-inspired athletic apparel company, propelling its stock above the $400 mark and marking a new 52-week high. Despite the challenging macroeconomic conditions and the retail landscape, LULU has managed to hold its own. This resilience was evident in its Q2 (July) results, where LULU outperformed, in contrast to other athletic retailers like Dick's Sporting Goods (DKS), Foot Locker (FL), and NIKE (NKE), which reported disappointing outcomes. Impressively, Q2 same-store comparisons stood at +11% (+13% on a constant currency basis), including in-store comps of +7% (+9% CC) and direct-to-consumer (DTC) comps of +15% (+17% CC). While consumers have been cutting back on discretionary spending, LULU's relatively higher price points did not prove to be a hindrance in Q2, as the company exceeded expectations and raised its outlook for the future. LULU's optimism for the second half of the fiscal year is supported by the fact that its customer base, which tends to be higher-income, hasn't felt the inflationary pinch as severely. LULU has also strategically expanded beyond its core yoga products. Its "Play" segment now includes tennis and golf collections, both of which have performed well. The Play strategy aims to cater to customers' unmet needs in their secondary athletic activities. LULU has also ventured into the footwear market, with steady progress and the recent introduction of Chargefeel 2, an updated versatile running and training style. The company is also set to launch a Men's footwear line in the coming year. While these segments are currently small, they hold significant growth potential over time. International expansion, particularly in Asia, is a key focus for LULU. In Q2, revenue in North America grew by a respectable 11%, but international sales surged by 52%. Notably, Greater China saw a remarkable 61% increase in sales. In July, LULU opened its first store in Thailand, marking the 100th location in the Asia-Pacific (APAC) region. The international segment's share of total sales increased to 22% in Q2, up from 17% a year earlier. The market's enthusiasm is evident as LULU receives recognition for joining the S&P 500. This move not only requires index funds to purchase LULU shares but also represents a significant milestone and achievement for the company. Nevertheless, it's important to acknowledge that challenges in the broader economic landscape persist. Some have suggested that LULU should expand into the wholesale channel to further boost sales, but management has been cautious in this regard. Their strategy prioritizes brand control, pricing management, and in-store presentation, which is best achieved through the company's own stores. Despite these considerations, this development is undoubtedly positive for LULU, and investors are pleased with the news.

Apple (AAPL) is currently experiencing some modest selling pressure in response to a Bloomberg report indicating that the company's latest iPhone 15 is off to a somewhat sluggish start in China, which happens to be Apple's third-largest market in terms of sales, accounting for approximately 19% of its revenue in FY22 (ending in September). Analysts estimate that iPhone 15 sales are tracking at a mid-single-digit percentage lower than its predecessor from the previous year. This relatively subdued performance of iPhone sales was somewhat anticipated, particularly after Apple issued a warning in early August, suggesting that its overall revenue, with over half of it attributed to iPhone sales, would see a similar year-over-year decline in Q4, mirroring the 1.4% drop observed in Q3. These figures reflect the ongoing challenges posed by global economic headwinds. However, what makes today's news slightly more concerning is that Apple's domestic rival, Huawei, appears to be bucking the trend in China. This could indicate a growing competitive challenge for Apple. Huawei's Mate 60 has gained substantial popularity in China since its launch in August. Notably, this phone features a processor manufactured by Semiconductor Manufacturing International (SMIC), the largest contract chip maker in China. The increased demand for this device, even at a price point similar to that of the iPhone 15 Pro, suggests a potential technological or aesthetic advantage. This contrasts with Apple's softer performance in the Chinese market. Apple experienced a positive uptick in China in the June quarter, with sales growing by 8% year-over-year, following a 3% sales decline in the previous quarter. This acceleration was seen as a promising sign and highlighted the importance of Apple's global diversification to offset any potential weakness in the United States. However, should sales in China decelerate in the September quarter, it could have a negative impact on Apple's overall financial results. It's worth noting that while Huawei is restricted from selling its devices in the United States and its allies, the company can conduct business in various emerging markets where Apple competes, including India, which recently achieved an all-time high in terms of sales for Apple. India and other emerging markets are pivotal for Apple's long-term growth strategy. Should rival smartphone brands encroach on its market, Apple may need to consider actions such as price reductions, which could impact profit margins. Today's report from Bloomberg paints a somewhat worrisome picture for Apple, especially with its September quarter earnings results approaching on November 2. Demand for discretionary goods, including smartphones and other consumer electronics, has been on the decline in the United States, Apple's largest market, which constitutes 43% of its FY22 revenue. If demand in overseas markets also falters, the year-over-year revenue for the September quarter may experience a more significant drop than initially anticipated. However, it's important to note that, despite criticism of iPhone's perceived lack of innovation in recent years, this hasn't translated into a significant decrease in demand. Consumer loyalty and Apple's technological edge, particularly on the software front, have contributed to its resilience. Therefore, while prominent overseas tech companies like Huawei may compete for market share, it might only result in short-term challenges rather than posing long-term structural problems for Apple.

Previous update:

The equities market is currently witnessing a significant impact stemming from Belden (BDC), a company specializing in network infrastructure and connectivity devices. BDC's stock has taken a sharp dive after it lowered its Q3 guidance, causing shares to reach their lowest point of the year. While the company didn't adjust its FY23 guidance downward, it expressed concerns about softening demand that is expected to persist into Q4, which will negatively affect its revenue and profitability. In their Q2 results announced earlier in August, BDC had raised their FY23 earnings per share (EPS) outlook due to stronger gross margins, although they slightly lowered revenue projections due to channel partners reducing their inventories.

Initially, BDC downplayed the impact of the inventory reduction, describing it as "temporary" and "slightly higher than anticipated." However, it is now evident that demand has significantly weakened, compounding the challenges posed by inventory reductions. The scale of the reduction in BDC's revenue guidance has caught market participants off guard, as they now anticipate Q3 revenue of around $625 million, in contrast to the previous guidance of $675-$690 million. This represents a year-over-year decline of about 7%, compared to the former projection of a 2% increase.

BDC did not specify in its press release which particular business segments or products are experiencing weaker demand, but the company operates primarily through two divisions: Enterprise Solutions and Industrial Automation Solutions. In Q2, Enterprise Solutions saw a modest 1% revenue growth compared to the robust 8% growth in Automation Solutions. Interestingly, a direct competitor of BDC's Automation Solutions, Cisco Systems (CSCO), reported strong Q4 results in mid-August, indicating healthy demand for routers, switches, and networking equipment. On the other hand, companies with greater exposure to 5G, data center, and home automation markets have been grappling with inventory destocking headwinds for several quarters.

Despite the substantial cut in revenue guidance, BDC only made a slight adjustment to its Q3 EPS guidance, now expecting $1.75-$1.77 compared to the previous range of $1.75-$1.85. Notably, BDC's gross margin has remained strong in the face of challenging demand conditions, with last quarter seeing a year-over-year expansion of 400 basis points to 38%. Taking a long-term view, BDC maintains optimism about its prospects, citing growing investments in automation and increasing bandwidth usage as primary drivers for its business. However, for the time being, the company faces a formidable combination of slowing demand and inventory destocking, making a substantial stock recovery unlikely.

SMART Global (SGH) has experienced a significant setback, with its stock plummeting by 44%, effectively erasing the gains it had made in 2023 and bringing it back to levels last seen in late October 2022. This decline followed disappointing Q4 (August) earnings and revenue results, as well as discouraging guidance for Q1 (November). SGH operates in several segments, including Memory Solutions, IPS (involving high-performance computing, AI, and IoT platform technologies), and LED Solutions. Despite a majority of its annual revenue originating from segments other than LEDs, SGH can be regarded as a company primarily focused on memory and data center technology. Its alarming Q4 performance has raised concerns as several prominent tech companies prepare to report their September quarter earnings in the coming weeks. The headline results were disheartening. SGH reported an adjusted EPS of $0.35, marking a decline of over 56% from the $0.80 recorded in the same period the previous year. This marked the company's first miss in over five years. Revenue also experienced a sharp decline, falling by 28% year-over-year to $316.66 million, the most substantial quarterly drop since the first quarter of 2019. This figure fell well short of SGH's initial forecast range of $350-400 million. What led to this disappointing performance? When SGH initially provided guidance for Q4 back in June, it included its Brazilian operations as part of its ongoing business. At that time, SGH had agreed to divest an 81% stake in SMART Brazil, but it didn't anticipate the deal closing until early 2024. Even if SMART Brazil's revenue was included in SGH's Q4 figures, it would have only partially met the quarterly forecast. Another factor contributing to the Q4 underperformance was orders within SGH's IPS business shifting from Q4 to Q1. The company did not foresee these delays when initially making its Q4 predictions, partly due to supply constraints that clouded inventory visibility. However, despite the order shifts, SGH's guidance still fell short of consensus expectations, with an estimated adjusted EPS and revenue range of $0.00-0.30 and $250-300 million, respectively. The core issue lies in weak demand. SGH's management acknowledged facing challenges due to ongoing market softness, with customers still working through their finished goods inventory. In particular, the high-performance computing (HPC) market within IPS remained unpredictable due to customer concentration, and in the Memory Solutions segment, demand for specialty products was lower than expected as inventories remained high. Despite these setbacks, there were some positive aspects, including a 3% sequential increase in LED Solutions revenue with improving customer design activity heading into FY24. SGH has also seen growing interest in its AI platforms, with enthusiasm surrounding the technology. Additionally, non-GAAP gross margins improved by 460 basis points year-over-year, reaching 31.7%, which reflects SGH's effective cost containment efforts. However, the wide misses in both revenue and earnings, along with the pessimistic guidance and prevailing macroeconomic challenges, have raised concerns, especially following strong results in the previous quarter. Notably, many of SGH's problems in Q4 were internal, which initially limited the impact on its peers until a broader market sell-off dragged them down. Still, SGH's results should not be underestimated as the earnings season approaches.

Citigroup (C) has provided a welcome relief during the Q3 earnings season for the banking sector, following concerns about the impact of high interest rates. Similar to JPMorgan Chase (JPM) and Wells Fargo (WFC), Citigroup surpassed expectations with robust results. After a prolonged slump spanning over a year, the investment banking sector saw a resurgence in Q3, and increased activity in fixed income trading also boosted the institutional side of the business. These positive developments bode well for Goldman Sachs (GS) and Morgan Stanley (MS), who are set to report their earnings next week. Despite apprehensions about rising interest rates, Citigroup's consumer banking and lending divisions have not been as adversely affected as feared by market participants. In fact, Citigroup raised its FY23 net interest income guidance to $47.5 billion or more, up from the initial projection of $46 billion, thanks to robust growth in personal loans and branded cards. Although there was a 10% quarter-on-quarter increase in net credit losses to $1.37 billion, Citigroup has managed loan write-offs effectively. Citigroup is also in the midst of a significant reorganization plan that will eventually lead to a 15% reduction in jobs and the elimination of management layers. These changes, set to impact Citigroup's Q4 results, are expected to further bolster earnings after a 9% increase in EPS this quarter. Delving into the driving forces behind this quarter's earnings growth, a few key factors stand out. Following a challenging Q2 with a 24% drop in investment banking revenue, a resurgence in debt and equity underwriting activities propelled a 34% increase in investment banking revenue, reaching $844 million. Citigroup's Markets business also experienced a 10% growth, bolstered by a 14% surge in fixed income trading revenue, particularly in rates and currencies related products. On the consumer banking front, the Personal Banking and Wealth Management (PBWM) segment achieved a 10% growth in total revenue. Branded Cards revenue increased by 12% due to higher interest rates, and average loans in U.S. personal banking expanded by 13%. Citigroup did increase its total allowance for credit losses on loans to $17.6 billion, up from $16.3 billion in the same period the previous year, which reflects a cautious stance on the overall economy. In summary, Citigroup's strong performance, coupled with impressive reports from JPM and WFC, has eased concerns that the current high-interest rate environment is significantly impacting the industry's financials. Additionally, the revival of the investment banking sector signals a positive shift away from the previously challenging conditions for deal-making.

JPMorgan Chase (JPM) is seeing a rise in its stock price today following the release of its impressive Q3 financial report. The bank reported substantial earnings per share (EPS) that exceeded expectations, resulting in a 3% increase in its stock value. Revenues also displayed a strong growth of 24.4% year-on-year, reaching $40.69 billion. Despite the belief that rising interest rates might benefit banks by allowing them to charge more for loans, it's important to note that higher rates also mean banks must pay more for deposits, which can lead to reduced loan demand, increased default risks, and heightened consumer caution. Therefore, the overall impact of higher rates on banks is not necessarily positive. In JPMorgan Chase's Consumer & Community Banking (CCB) segment, revenues experienced a healthy 29% year-on-year growth, reaching $18.36 billion. Consumer spending growth has reverted to pre-pandemic levels, with nominal spend per customer remaining relatively stable year-on-year. Banking & Wealth Management revenues reached $11.3 billion, marking a 43% increase, or 30% when excluding First Republic, driven by higher net interest income, partly offset by lower balances. Home Lending revenues were $1.3 billion, showing a 36% increase, or a 2% decrease when excluding First Republic. Card Services & Auto revenues rose by 7% to $5.8 billion. In the Corporate & Investment Bank (CIB) segment, revenues saw a 2% year-on-year decline, amounting to $11.73 billion. Markets revenue dropped by 3% to $6.6 billion, and Investment Banking revenues declined by 6%, mainly due to lower advisory fees. Payments revenue increased by 3%, primarily driven by higher rates. The bank expressed optimism about the level of capital market activity in September, indicating a healthy pipeline heading into Q4. While advisory activities picked up in comparison to the first half of 2023, announced M&A deals have lagged significantly year-to-date, which presents a challenge. Commercial Banking (CB) revenues surged by 32% year-on-year, reaching $4.03 billion, and Asset & Wealth Management (AWM) revenues increased by 10% to $5.0 billion. Most segments demonstrated robust performance. JPMorgan Chase allocated $1.4 billion for the provision of credit losses, reflecting net charge-offs of $1.4 billion and a net reserve build of $47 million, which included a net build of $301 million in Card Services and a net release of $250 million in Home Lending. JPMorgan Chase indicated that both US consumers and businesses are generally in good financial health, although consumers have been gradually reducing their excess cash buffers. Nonetheless, tight labor markets and the high levels of government debt increase the risks of sustained inflation and further interest rate hikes. The ongoing conflict in Ukraine, compounded by recent attacks on Israel, could have wide-ranging effects, according to the bank's assessment. JPM's CEO, Jamie Dimon, stated, "This may be the most dangerous time the world has seen in decades." Overall, investors have responded positively to JPMorgan Chase's strong Q3 results, with the bank performing well across its various segments. Consumer banking, in particular, demonstrated strength, and the bank's outlook on consumers as the holiday season approaches has been optimistic. While some macroeconomic concerns were mentioned, they were consistent with previous statements. In conclusion, this quarter's results from JPMorgan Chase, along with strong earnings reports from other banks, bode well for the upcoming bank earnings season next week.

UnitedHealth (UNH) is maintaining its positive momentum after an impressive Q3 performance, driven by a decrease in its medical care ratio (MCR), a key indicator that represents the percentage of premiums used to cover claims. This aligns with management's previous remarks and has bolstered UNH's stock. The favorable MCR data enabled UNH to exceed analyst expectations by the largest margin in a year while sustaining strong revenue growth year-on-year. This marks the 13th consecutive time UNH has surpassed expectations. As a bellwether for the health insurance industry, UNH's strong results are also lifting the prospects of its competitors, including Humana (HUM), Centene (CNC), Molina Healthcare (MOH), and The Cigna Group (CI), all of which are set to report their Q3 earnings in the coming weeks. In Q3, UNH saw a 13.3% year-on-year growth in earnings, reaching $6.56, maintaining its record of double-digit beats. Revenue also remained robust, increasing by 14.2% to $92.36 billion, with growth evident in both UnitedHealthcare and Optum, recording 13% and 22% improvement, respectively. While Optum's operating margins contracted year-on-year, slipping by 100 basis points to 6.9%, it continued to witness growth in operating earnings, rising by 5.4% year-on-year to $3.9 billion. The MCR showed a slight increase of 70 basis points year-on-year to 82.3%, driven by ongoing outpatient care demand, particularly among seniors, and a rising number of individuals seeking mental health support compared to pre-pandemic levels. However, UNH's MCR decreased by 90 basis points sequentially, consistent with management's expectations from the previous quarter. This sequential decline is primarily attributed to seasonality, where the summer encourages outdoor activities, causing people to delay outpatient procedures until the winter months when they spend more time indoors. Additionally, the consistent pace of care activity has allowed UNH to better predict its MCR's quarter-to-quarter performance. Due to the MCR decrease stemming from seasonality, UNH anticipates a slight marginal decrease in Q4 earnings compared to Q3, which is why the company only made a slight adjustment to its FY23 earnings outlook. UNH now expects earnings per share (EPS) to be in the range of $24.85-$25.00, with the low end raised by $0.15 from its previous forecast. Overall, UNH had a strong quarter, leading to positive trends in its stock performance. Since the beginning of September, UNH's stock has increased by around 12%, turning positive for the year after a turbulent first half. While investors initially reacted with concern to price cuts in UNH's Medicare Advantage program by the CMS, set to take effect in 2024, the company had ample time to adapt its cost structure following the CMS warnings issued months in advance. The consistent patient care activity in recent quarters has also eased concerns of a sudden spike in UNH's MCR. As a result, UNH continues to be a sound long-term investment, especially during challenging economic conditions.

Previous update:

Fastenal (FAST) has reported strong Q3 results, exceeding analyst expectations and achieving 52-week highs. While the company's financial performance is robust, concerns arise from management's cautious outlook on the broader economy. Macro indicators suggest sluggish demand, which is a potential headwind for FAST, despite a +5% increase in its September daily sales rate. The company attributes this growth more to easing comparisons than a clear indication of strengthening customer demand. As a significant distributor of industrial and construction supplies, FAST's performance reflects manufacturing activity. Revenue growth in Q3 reached $1.85 billion, expanding 2.4% YoY, exceeding Q2 expectations. Adjusted EPS of $0.52 marked a 4.1% YoY increase. FAST's strategic growth drivers include expanding Onsite locations and maintaining new Onsite signings. However, while Q3 performance improved, concerns linger regarding stagnant demand, especially in the fasteners segment.

Delta Air Lines (DAL) faced turbulence due to rising fuel and maintenance costs but reported Q3 results in line with revised guidance. Higher fuel and maintenance expenses have been impacting margins and profits across the airline industry. DAL's average fuel cost per gallon rose by approximately 10% to $2.78 QoQ, while non-fuel CASM increased by 1.3%. The question of whether demand is weakening as discretionary spending slows remains pertinent. DAL's Q4 revenue outlook indicates growth of 9-12%, consistent with expectations. International travel has shown strength, with passenger revenue increasing by 35% YoY. Domestic travel, while not as robust as in previous years, remains healthy. Business travel is improving as corporations announce return-to-office initiatives. Premium and loyalty revenue have also increased by 17%. However, DAL's unit revenue trends are declining as it adds capacity, with Q4 total unit revenue expected to decrease by 2.5% to 4.5%. The airline faces potential challenges due to falling ticket prices and rising oil prices.

Domino's Pizza (DPZ) saw a surge in its stock price as it reported its most significant earnings per share (EPS) beat in the past five years, along with positive comments on comparable sales trends. However, Q3 sales fell slightly short of analyst expectations, and the Q3 US comparable sales took a dip into the negative territory, which was a disappointment for investors. The US comparable sales saw a decline of -0.6%, following a lackluster +0.1% in Q2. The decline was attributed to a decrease in order counts, partially offset by higher average ticket prices that included pricing actions. DPZ has witnessed underwhelming comparable sales for two consecutive quarters, marking a declining trend this year: +3.6% in Q1, +0.1% in Q2, and now -0.6% in Q3, despite a 3.2% average price increase. On a more positive note, international comparable sales (excluding foreign exchange effects) remained relatively stable at +3.3%, in line with Q2's +3.6%. DPZ's US carryout business remained strong in Q3, with comparable sales at +1.9%, even after facing the challenge of lapping a substantial +19.6% comparison from the previous year. However, the delivery business continued to be weak, albeit in line with management's expectations, with US delivery comparable sales at -2.3%, despite the comparison of -7.5% from the previous year. Looking ahead, DPZ anticipates a return to positive territory for total US comparable sales in Q4, with delivery comparable sales expected to improve, thanks to an updated loyalty program and the rollout of an emergency pizza promotion. Moreover, DPZ foresees "considerable improvement" in 2024, driven by transaction growth from its Uber Eats partnership and other previously shared initiatives. While the report featured various mixed results, including less impressive revenue and comparable sales figures, investors seemed encouraged by management's positive outlook for delivery trends in Q4 and beyond, especially with the full implementation of the Uber Eats partnership. This optimism persisted despite the expectation of pricing providing less of a tailwind in Q4.

Walgreens Boots Alliance (WBA) has closed the final quarter of FY23 under the former CEO Rosalind Brewer's leadership, marking the beginning of a fresh start for FY24. While WBA exceeded Q4 revenue expectations, it fell short of earnings forecasts, coming in one cent below the low end of its projected earnings range of $0.68-0.73. Moreover, WBA's FY24 guidance, including earnings and the midpoint of revenue, was below consensus estimates. Despite these challenges, investors are looking forward to a more promising future under the newly appointed CEO, Tim Wentworth, after a turbulent year that saw downward revisions to annual outlook, weakening demand, and Brewer's departure. A positive aspect of WBA's Q4 report was the reiteration of restructuring initiatives, such as planned cost reductions of at least $1.0 billion and a reduction of approximately $600 million in capital expenditure, set to benefit FY24 starting in Q2 (February). WBA has already initiated actions like store closures, changes in operating hours, and the implementation of artificial intelligence. The return of executives to the office is expected to expedite priority projects. Despite challenging macroeconomic conditions and reduced contributions from COVID-19, WBA reported a 9.2% year-over-year revenue increase, with Q4 earnings per share at $0.67 and revenues at $35.42 billion. Signs of growth on the horizon include WBA's projection of FY24 revenue in constant currency to expand between 1% and 4% year-over-year, with reported revenue growth at the midpoint of its $141-145 billion outlook. While FY24 earnings per share are expected to decline from $3.99 in FY23 to $3.20-3.50, this decrease is primarily attributed to reduced COVID-19 contributions and persistent inflationary pressures on consumers. The forecast assumes underlying growth, supporting improved profitability for the U.S. Healthcare segment. WBA faces challenges in the coming quarters, including shifting consumer behaviors, lower sale-leaseback gains, and a decline in COVID-19-related tailwinds, which may limit short-term financial performance. However, the company anticipates accelerated synergies between U.S. Healthcare and WBA operations, modest FY24 growth following a 5% increase in FY23, and a new leader with extensive experience in the healthcare industry. While WBA's turnaround is a risky endeavor, it differs from struggling competitor Rite Aid (RAD), which is teetering on the brink of bankruptcy. WBA's vast global presence with nearly 9,000 stores, strong brand recognition, and expanding primary care offerings make it a formidable candidate for a successful comeback.

Previous update:

Birkenstock's (BIRK) highly anticipated initial public offering (IPO) faced a disappointing reception, dashing the initial optimism that surrounded it. Investors had high hopes, given the strong IPO performances of companies like Arm Holdings, Instacart, and Klaviyo. However, the Germany-based sandal maker priced its 32.26 million share IPO at $46, slightly below the expected range of $44-$49. This pricing came as a surprise because earlier reports had suggested a higher valuation. The concern may have stemmed from the company's lofty valuation, with a $49/share price putting its market cap at around $11.0 billion, which seemed steep, particularly considering the slowdown in consumer spending, including for footwear. Adding to the unease was the lukewarm performance of recent IPOs like Arm, Instacart, and Klaviyo, with Instacart trading 10% below its IPO price. Consequently, Birkenstock's IPO opened at $41, around 11% below the IPO price. Despite this disappointing start, there is still potential for Birkenstock, as the lower market cap of approximately $7.8 billion makes its valuation more attractive. The company's strong brand, history of weathering economic downturns, and consistent profitability are its assets, offering hope for its future, even though its IPO debut was a stark reminder of the IPO market's fragility.

In the case of Sherwin-Williams (SHW), the company initially saw a positive market response after announcing the appointment of a new CEO, Heidi Petz, succeeding John Morikis, who would remain as Executive Chairman. This move was part of a multi-year succession plan. Despite Ms. Petz's qualifications, the market's enthusiasm was tempered by several factors. While the market had been encouraged by healthy demand trends in previous quarters, the rising mortgage rates since Sherwin-Williams' Q2 results could potentially hinder new home starts, a significant source of the company's revenue. Furthermore, the company's strong businesses like Auto Refinish and General Industrial might start experiencing softness due to higher interest rates, affecting auto OEM demand and housing upgrade demand. While peer RPM Inc had positive numbers due to improving overseas conditions, Sherwin-Williams relies heavily on domestic demand and may not benefit from the same international growth. RPM's commentary about a weak U.S. housing market raised concerns ahead of Sherwin-Williams' Q3 report. While the market typically welcomes new CEOs with initial excitement, this enthusiasm can fade as investors digest the changes, and given the uncertain macroeconomic environment, investors are approaching Sherwin-Williams' upcoming Q3 report with caution.

Exxon Mobil's (XOM) significant move to solidify its presence in the Permian Basin through a major acquisition of Pioneer Natural Resources has garnered attention. Approximately a week after the Wall Street Journal's initial report in mid-April, it was revealed that Exxon Mobil (XOM) was on the brink of a colossal merger with Pioneer Natural Resources (PXD), estimated to be worth around $60 billion. This mega-deal, marking the largest in the oil and gas sector in over two decades, has now materialized. Exxon Mobil has agreed to acquire Pioneer Natural Resources for $253 per share in an all-stock transaction, valuing the deal at roughly $59.5 billion. This purchase price represents an 18% premium over Pioneer Natural Resources' closing stock price on October 5, the day the Wall Street Journal first disclosed the potential merger. Despite the news causing Pioneer Natural Resources' stock to trade higher, it is still below the $253 per share acquisition price, partly due to concerns that the deal may face intense antitrust scrutiny from regulators, raising questions about its approval. Executives from Exxon Mobil and Pioneer Natural Resources argue that the merger would enhance the country's energy independence and benefit consumers by lowering drilling and recovery costs through operational integration. However, the verdict from lawmakers and regulatory bodies like the Federal Trade Commission (FTC) and Department of Justice (DoJ) is yet to be determined, and the gap between Pioneer Natural Resources' stock price and the acquisition price reflects this uncertainty. If the deal is approved, Exxon Mobil will become the dominant producer in the Permian Basin by a significant margin. The numbers associated with this merger are substantial. The combined Exxon Mobil and Pioneer Natural Resources would have an estimated 16 billion barrels of oil equivalent resources in the Permian, and Exxon Mobil's Permian production would more than double to 1.3 million barrels of oil equivalent per day (MOEBD) based on 2023 volumes, with expectations of reaching around 2.0 MOEBD by 2027. This would give Exxon Mobil a competitive edge over rivals like Chevron and ConocoPhillips. The Permian's quicker and cost-effective resource extraction provides Exxon Mobil with enhanced flexibility and cost-efficiency in adjusting production levels. Additionally, Exxon Mobil stated that the acquired Pioneer Natural Resources assets would remain profitable even if crude oil prices drop as low as $35 per barrel. Despite the evident advantages of the deal, Exxon Mobil's stock has experienced a significant decline due to the all-stock nature of the transaction. Rather than relying on expensive debt to finance the acquisition, the company is leveraging its elevated stock price, which has risen by more than 80% since the beginning of 2022. Exxon Mobil's acquisition of Pioneer Natural Resources is a transformative event with far-reaching implications, not only for the companies involved but also for the broader oil and gas industry and the stock market as a whole. A deal of this magnitude could potentially trigger increased M&A activity, which might benefit the market; however, formidable regulatory and antitrust concerns present substantial challenges that this deal and others in the future will need to overcome.

HP Inc. (HPQ) is on the path to recovery, aiming to regain investor confidence after offering its in-line earnings guidance for fiscal year 2024 and increasing its annual dividend by 5% to $1.1024 per share, resulting in a 4.2% yield. HPQ's stock has faced a rapid and prolonged decline over the past few months, declining by approximately 20% since the start of August. The company's Q3 (July) earnings results in late August contributed to the stock's downward trajectory, as it marked the third consecutive quarter with lower-than-expected sales and provided a modest Q4 (October) outlook. Nonetheless, the initial FY24 adjusted EPS forecast of $3.25-3.65, even though it fell slightly short of consensus expectations, has eased the substantial selling pressure. This is noteworthy because one of the primary reasons investors reacted negatively to HPQ's Q3 results was its struggle to meet the expectations of an improved second half of the year compared to the first half. Today's FY24 guidance suggests that the demand landscape may be taking a bit longer to recover. The company also detailed its cost-saving expectations for the next couple of years, a key factor contributing to its year-over-year EPS improvement. HPQ anticipates that its "Future Ready" cost-saving initiative will yield an additional $200 million in annualized gross run-rate structural cost savings, reaching a total of $1.6 billion by the end of fiscal year 2025 (October), while incurring charges of about $1.0 billion. One of the positive aspects of Q3 was HPQ's "Future Ready" plan, which bolstered its bottom line and helped it maintain its margins despite challenging market conditions. HPQ mentioned that its cost-saving plan was progressing as planned, aligning with its long-term growth priorities. This is reflected in the company's initial FY24 free cash flow projection of $3.1-3.6 billion, which shows potential improvement over FY23. While HPQ initially believed that the macroeconomic situation was not improving as rapidly as anticipated in August, Dell (DELL) contradicted this viewpoint by stating that the demand environment was better than expected and raising its FY24 (January) guidance. Furthermore, Gartner recently reported that PC shipments, which declined by 9% in the September quarter, are expected to rebound during the December quarter. However, given HPQ's substantial reliance on printing revenue (approximately 30% annually), it may not fully capitalize on an improving PC market. It is also worth noting that major shareholder Warren Buffett has been reducing his stake in the company, with several sales over the past few months. In conclusion, HPQ's announcements today are encouraging, and its stock has become more appealing from a valuation perspective after the extended sell-off, trading at around 8x forward earnings, offering a decent discount compared to Dell at 10x. While a degree of caution is warranted due to near-term challenges facing HPQ, the company may be approaching a bottom in terms of demand, especially with the favorable holiday season ahead.

Previous update:

Unity Software (U) has experienced a significant development as its Chairman and CEO, John Riccitiello, announced his immediate retirement. This unexpected move has brought James Whitehurst, an outsider, into the role of Interim CEO, while Roelof Botha, the Board's Lead Independent Director, will take on the position of Chairman. Despite Riccitiello's nine-year leadership and Unity's IPO in 2020, the company has struggled in the stock market, with shares plummeting over 80% from their peak in November 2021 and currently trading 40% below their IPO price of $52. Factors contributing to this decline include the impact of rising interest rates, a controversial pricing model, and questionable M&A decisions. However, the change in leadership has sparked optimism among investors, particularly given Unity's presence in the gaming industry, potentially paving the way for a turnaround.

Meanwhile, Honeywell (HON), a prominent industrial company, has announced a strategic restructuring plan to streamline its operations and focus on core growth strategies, aligning with key megatrends that are expected to shape its future. Beginning in the first quarter of 2024, Honeywell will consist of three segments: Aerospace Technologies, Industrial Automation, and Building Automation. This realignment aims to position the company strategically in response to trends like the future of aviation and energy transition. Honeywell's Aerospace division has been a significant driver of its growth, benefiting from the recovery in commercial aviation demand. The company is also de-emphasizing the oil and gas industry in favor of energy transition initiatives. However, market reactions to this announcement have been relatively muted, reflecting uncertainty about whether this restructuring will substantially impact Honeywell's growth prospects, as much of its business is tied to the cyclical nature of the global economy.

Coherent (COHR) has experienced a significant surge in its stock price following the announcement of a strategic deal with Japan's DENSO and Mitsubishi Electric. These two companies will each invest $500 million for 12.5% stakes in Coherent's silicon carbide (SiC) business, valuing the SiC unit at an impressive $4 billion. Coherent, a renowned supplier of various high-tech components, plans to retain a 75% ownership stake in the SiC business while establishing it as a separate subsidiary. This move aligns with Coherent's strategic review of its SiC segment initiated earlier in May 2023. Coherent's SiC technology is generating considerable enthusiasm due to its potential in the electric vehicle (EV) and hybrid vehicle markets. SiC substrates, which enhance the energy efficiency of these vehicles' power electronics, are a key focus area. SiC-based power electronics offer advantages such as improved power utilization, higher conversion efficiencies, lower operating temperatures, and reduced thermal loads. These benefits translate into increased driving range or reduced battery capacity requirements, resulting in significant cost savings. Notably, Coherent will maintain control and operation of the SiC business, and the deal extends beyond mere financial investment. Long-term supply agreements will be established with DENSO and Mitsubishi Electric, ensuring a stable supply of SiC wafers to these industry leaders in SiC power devices and modules. Mitsubishi Electric's decision to expand its SiC power semiconductor production capacity underscores the expected exponential growth in demand for SiC power semiconductors. Market estimates suggest that the SiC total addressable market will grow from $3 billion in 2022 to a substantial $21 billion by 2030. Coherent has committed substantial resources to SiC technology over the past two years, including significant investments in capital and research and development. This commitment is part of a 10-year, $1 billion initiative launched in August 2021 to expand the manufacturing of SiC substrates and epitaxial wafers. The transaction is slated to close in the first quarter of calendar year 2024. Investors have responded positively to this strategic development, especially given the $4 billion valuation placed on the SiC business. This valuation not only validates Coherent's previous optimistic remarks about its SiC technology but also signifies the company's potential for robust growth in the coming years. Moreover, the supply agreements with major SiC wafer consumers, DENSO and Mitsubishi Electric, demonstrate a shared interest in the success of Coherent's SiC business beyond financial considerations.

PepsiCo (PEP) has experienced a resurgence in its stock value, driven by a robust Q3 performance, increased volumes, and optimistic guidance for FY23 and FY24. Recent concerns over weight-loss medications potentially affecting consumer food consumption, combined with inflation-induced softness in demand, had contributed to a decline in PepsiCo's share price. Retailers like Walmart had reported a decrease in food-shopping demand due to appetite-suppressing drugs from companies like Novo Nordisk and Eli Lilly. However, some industry players like Conagra and General Mills didn't express immediate concern over the impact of these drugs on their volumes during recent earnings calls. PepsiCo shared a similar sentiment, stating that the impact of weight-loss treatments on its business has been minimal so far. The company highlighted uncertainties regarding medical testing, scalability, and global adoption of these drugs. Moreover, PepsiCo has been actively adapting its product portfolio to align with changing consumer preferences and nutritional needs, launching new products and transforming existing ones. In Q3, PepsiCo demonstrated strong performance, with a 14% year-over-year increase in adjusted EPS to $2.25 and a 7% rise in revenue to $23.45 billion. Organic revenue, excluding foreign exchange impacts, increased by 9% year-over-year. Volumes showed improvement compared to the previous quarter, with modest declines in Convenient Foods volumes (1.5%) and flat Beverages volumes, an improvement from Q2. Geographically, North America witnessed a 6% volume decline in Beverages, while Frito Lay and Quaker Foods volumes remained flat and increased by 1%, respectively. In Latin America, Beverages experienced strong demand, resulting in a 5% volume increase year-over-year, while Convenient Foods volumes fell by 5%. Other regions, including Europe and Asia, reported volumes largely in line with PepsiCo's overall figures. Looking forward, PepsiCo raised its FY23 earnings outlook to an adjusted EPS of $7.54, up from $7.47, and reiterated its organic revenue growth forecast of +10%. The company acknowledged changing consumer behaviors, such as downsizing or opting for smaller sizes, but noted healthy demand in channels like convenience and food service. PepsiCo also provided guidance for FY24, anticipating results at the upper end of its long-term targets for organic revenue growth (+4-6%) and high-single-digit percentage year-over-year constant currency EPS growth. Despite recent concerns and a decline in share prices, PepsiCo's consistent earnings performance and volume improvements suggest that the market reaction may have been overstated. Current price levels could be seen as an attractive entry point for long-term investors.

Previous update:

Tyson Foods (TSN) is facing a challenging period as its shares hit new lows over the past year, with investors showing reluctance to invest. The recent report in the Wall Street Journal highlights the economic consequences of Tyson Foods closing one of its plants in Missouri, keeping the unfavorable demand situation in the spotlight. Tyson Foods had previously announced plans to close four chicken facilities across the U.S., in addition to two other plant closures, while also considering the possibility of further closures. Despite shares trading at their lowest levels in several years, several obstacles are impeding Tyson Foods' recovery in the near term. One significant concern is the potential resurgence of avian flu (HPAI), which could adversely affect the company's financials. Although HPAI did not have a significant impact on Tyson Foods' operations in the second quarter, it disrupted key export markets and lowered the company's chicken-related operating margins. The ongoing presence of HPAI in the wild bird population raises concerns about future outbreaks. Additionally, Tyson Foods is in the midst of a restructuring effort, involving plant closures and layoffs. While there have been some benefits from these initiatives, weak demand and declining prices have contributed to disappointing earnings results over the past two quarters. Tyson Foods faces competition from other food processors and cheaper protein alternatives, as its products, including raw chicken, beef, and pork, are easily replicable commodities with limited brand loyalty. Instead, Tyson competes based on volume, leveraging its global presence. However, in the current environment of weak demand, where consumers seek lower-cost protein options, Tyson has struggled to capitalize on its volume advantage, with flat or declining volumes in five of the last eight quarters. In conclusion, Tyson Foods is grappling with numerous challenges in the global economy, and its shares have reflected this negativity by reaching multi-year lows. It may be wise to wait for confirmation of stabilized demand before considering a long-term investment in the company.

Datadog (DDOG) faced a downgrade from BofA Securities today, causing a 4% drop in its stock price. The observability and security SaaS platform for cloud applications was downgraded from a "Buy" to a "Neutral" rating. This marks the second rating reduction since DDOG's Q2 earnings report in August, following a recent upgrade and an "Outperform" rating initiated by TD Cowen a month earlier. While there are positive factors at play, such as the increasing demand for real-time IT environment observability and cloud monitoring due to digitalization trends, several challenges are affecting DDOG's short-term prospects. One significant challenge is the highly competitive nature of the observability sector. Established giants like Amazon, Microsoft, Cisco, and Splunk, as well as emerging players like New Relic, pose considerable competitive risks as DDOG seeks to strengthen its position in the enterprise market. This competitive pressure may have already impacted DDOG's recent quarterly performance. In Q2, DDOG experienced a slight slowdown in new customer growth, with a 23% year-over-year increase compared to a 29% improvement in Q1. Additionally, higher churn was observed among lower-tier customers, although management noted that some of this churn was related to customer consolidation onto the platform, an ongoing process. Unfavorable economic conditions have also affected DDOG. The company operates on a consumption-based model, which means its revenue fluctuates based on customer usage. During challenging economic periods, customers tend to reduce their consumption, which has contributed to DDOG's declining revenue growth over the past several quarters. DDOG's post-Q2 sell-off was partly attributed to existing customers reducing their consumption more than competitors, although management dismissed this as a result of a different customer mix. Furthermore, DDOG's relatively high valuation multiples, trading at 58 times forward earnings and 12 times forward sales, could hinder short-term appreciation, even though 2023 has seen less emphasis on valuations due to the potential of AI. DDOG's downbeat sales outlook for FY23, falling short of consensus, was seen as a significant concern given its premium valuation. While there were positive signs in Q2, such as stabilization among existing customers and increased adoption of multiple products, the uncertain near-term demand landscape suggests caution. It might be prudent to wait for further evidence of stabilization trends in the coming quarter before considering an investment in DDOG.

Levi Strauss (LEVI) saw its stock initially decline following its Q3 (Aug) earnings report, despite a slight earnings per share (EPS) beat. Unfortunately, the revenue figures fell slightly short of expectations, and the company adopted a "cautious approach" for its Q4 (Nov) outlook. Consequently, LEVI anticipates that its adjusted EPS for FY23 will fall towards the lower end of its prior guidance range of $1.10 to $1.20, and it has adjusted its revenue growth outlook for FY23 to +0-1% from +1.5-2.5%. The company's strong double-digit growth in its direct-to-consumer (DTC) business, which encompasses e-commerce and company-operated stores, was counterbalanced by persistent weakness in the wholesale channel, particularly in the United States. LEVI has been actively shifting its focus towards becoming a DTC-centric company and has initiated a review of its operating model and cost structure to generate significant cost savings beginning in 2024. In Q3, the DTC channel delivered robust growth of 14% (+13% on a constant currency basis), driven by widespread expansion in both stores and e-commerce. DTC demonstrated positive comps across all regions and across mainline, outlet, and e-commerce segments. E-commerce revenue grew by 19% (+18% CC), reflecting double-digit growth across all brands. In the United States, DTC business grew by 10%, and US mainline, the segment featuring its premium products, experienced double-digit comp growth. DTC accounted for 40% of total revenue in Q3. However, the wholesale channel remained a weak point with an -8% (-10% CC) decline in revenue. Growth in Asia and Latin America partially offset declines in North America and Europe. LEVI is actively working to stabilize the wholesale channel, and early indications following price reductions implemented in US wholesale late in Q3 are positive. The company has started to observe the impact of reduced inventories and improved fill rates. LEVI anticipates a sequential improvement in US wholesale trends, with customer fill rates returning to normalcy in Q4, leading to greater product freshness ahead of the critical holiday season. While DTC is the primary focus, LEVI acknowledges the importance of the wholesale business, as it amplifies its brands, provides consumer access, and contributes to profitability. However, wholesale will become a smaller component of its overall mix over time. Despite challenges in US wholesale, LEVI asserts that its brand is at one of its strongest points ever. Average unit retail prices (AURs) have continued to rise, even as LEVI strategically lowered prices in the US wholesale channel at the end of Q3, primarily due to product mix. LEVI is also increasing its market share among higher-income consumers and experiencing strength in its full-price mainline (non-outlet) store segment. The Levi's brand is gaining US market share. In summary, LEVI's Q3 results and outlook have disappointed investors, leading to the stock trading at a new three-year low. The struggle in the US wholesale business is evident, while DTC and international segments remain bright spots. The challenges faced by a prominent brand like Levi's underscore the impact of macroeconomic factors. Caution may be warranted before considering investments, especially until the US wholesale segment stabilizes. Kontoor Brands (KTB), which owns Wrangler and Lee jeans, saw its stock lower in sympathy, with KTB typically reporting earnings in early November.

Previous update:

Aehr Test Systems (AEHR), a company specializing in burn-in and testing equipment for semiconductor production, faced a significant drop in its stock price despite delivering strong results for the first quarter of 2024. The company reported robust growth, with revenues surging by 93% year-over-year to reach $20.6 million, driven primarily by increased demand from electric vehicle (EV) manufacturers for silicon-carbide power chips. CEO Gayn Erickson described this performance as the company's "strongest first quarter in its history," even though it was the seasonally slowest quarter. However, the stock saw a sharp decline, primarily due to disappointment in AEHR's guidance. Instead of raising its full-year 2024 guidance, the company decided to reaffirm it, forecasting revenue of at least $100 million, in line with analyst estimates. With a relatively high price-to-sales ratio and concerns about the sustainability of EV demand amid potential interest rate hikes, investors chose to sell their positions, especially after the stock had already rallied by nearly 120% in 2023. Nevertheless, AEHR still has positive developments, including a significant increase in design volume, expanding customer interest beyond EVs, and growth potential in gallium nitride applications.

Levi Strauss (LEVI) reported its Q3 (August) results, which initially led to a flat stock performance after an initial dip. While the company managed to slightly beat earnings per share (EPS) expectations for the quarter, its revenues fell slightly short, and management adopted a cautious outlook for Q4 (November). LEVI expressed expectations of FY23 adjusted EPS being at the lower end of its previously guided range of $1.10 to $1.20 and lowered its FY23 revenue growth projection from +1.5-2.5% to +0-1%. The challenge stems from the company's ongoing shift towards being a direct-to-consumer (DTC) led business. Its DTC channel achieved 14% growth, driven by both retail stores and e-commerce. In contrast, the wholesale channel, especially in the US, continued to underperform, declining by 8%. Levi's is actively working to stabilize its wholesale channel, including implementing price reductions and improving fill rates. Despite challenges in the US wholesale segment, Levi's brand remains strong, growing market share, and delivering growth in average unit retail prices (AURs). However, investors reacted cautiously to the weaker wholesale performance, resulting in the stock trading at a new 3-year low. While DTC and international segments show promise, Levi's US wholesale business presents challenges, highlighting the impact of macroeconomic conditions on even well-established brands like Levi's. Investors may exercise caution before considering investment in the company, especially awaiting signs of stabilization in its US wholesale segment.

Exxon Mobil (XOM) is on the brink of sealing a significant deal to acquire Pioneer Natural Resources (PXD), a noteworthy oil and gas producer, with reports suggesting a potential blockbuster agreement worth approximately $60 billion. While the deal has not yet been finalized, this development has led to a sharp surge in PXD's share price, while XOM's stock is experiencing a decline as investors grapple with the prospect of the company executing the largest acquisition of the year. With a market capitalization of approximately $435 billion, XOM can comfortably absorb PXD, despite its much smaller size, but financing the deal may necessitate tapping into capital markets. XOM's cash and cash equivalents stood at about $29.5 billion as of June 30, 2023, while its total debt was substantial at $41.5 billion. However, there are concerns about the timing of this potential mega-deal. Crude oil prices have been trending lower, and this trend could persist if the U.S. dollar strengthens further or if economic conditions deteriorate, potentially leading to weaker oil demand. Recent events, such as a strong September jobs report that raised yields and the U.S. dollar, may further pressure commodity prices. Despite these challenges, XOM's interest in acquiring PXD aligns with its strategic goals, especially considering that adding PXD would make XOM the dominant producer in the Permian Basin, a region with attractive drilling economics. XOM's strong performance in the Permian Basin accounted for over 50% of its net U.S. oil and gas production in 2022, with production increasing by 20% to over 550,000 oil-equivalent barrels per day. Given XOM's size, few M&A opportunities can significantly impact the company, but PXD is one of them. In 2022, PXD generated impressive revenue and cash flow from operations, and at a $60 billion transaction value, XOM would likely pay a reasonable price with a Price/EBITDA ratio of around 6-7x, based on PXD's expected EBITDA in 2024. While the deal is substantial, the integration risks should be manageable, given XOM's existing presence in the Permian Basin and minimal changes to its business model. However, this acquisition represents a major move for XOM in the fossil fuels sector, contrasting with other energy companies like Shell and BP, which are increasingly focusing on renewable energy. The key concern is that declining crude oil prices could impact the deal's timing, potentially enabling XOM to negotiate a lower purchase price if commodity prices continue to slide.

Exxon Mobil (XOM) has reported stronger profits for Q3, with an estimated operating profit in the range of $5.2 billion to $6.7 billion for its oil and gas business. This update suggests that XOM's Q3 earnings will likely align with analysts' expectations and serves as a positive sign for the sector as the earnings season approaches. However, the optimism surrounding Q3 results is being overshadowed by a sharp decline in crude oil prices this week, driven by reports of significant increases in gasoline inventories and rising macroeconomic concerns amid higher interest rates. Additionally, XOM's stock had already surged by approximately 10% since August before the recent selloff, indicating that the market had priced in a strong quarter. XOM experienced improvements across most of its businesses, primarily driven by higher crude oil prices, which boosted operating profit in the upstream business by $900 million to $1.3 billion. Furthermore, refining margins saw substantial increases in Q3, despite increased crude oil production in the U.S., as supply cuts from OPEC+ and robust global demand for gasoline, jet fuel, and other products led to strong refining margins. However, the Chemicals business continued to face weakness, with an operating profit decline of $400 million to $600 million due to contracting industry margins. While higher oil and gas prices contributed to a robust Q3 for XOM, market participants are looking beyond these results as they express concerns about declining commodity prices, which could signal a more challenging quarter ahead.

Lamb Weston (LW) is on the path to a turnaround following its Q1 (August) earnings report, which exceeded bottom-line estimates by the largest margin in over five years and prompted an optimistic revision of its FY24 (May) outlook. Although the global potato producer experienced an 8% decline in volumes compared to the previous year, this was primarily due to LW's deliberate exit from lower-priced, lower-margin businesses and the lingering effects of inventory destocking. LW anticipates a gradual improvement in volumes as the year progresses. Q1 showcased impressive numbers, with adjusted EPS reaching $1.63, marking a substantial 117% year-over-year increase, while revenues surged by 48.0% to $1.67 billion, marking the second consecutive quarter of above-40% growth. It's worth noting that a significant portion of LW's robust sales growth stemmed from recent acquisitions, particularly in its EMEA business. When excluding the impacts of these acquisitions, sales grew by 15% year-over-year. Over the past few quarters, LW has seen substantial margin improvements by exiting lower-margin businesses, even during Q1, which is typically its lowest-margin quarter due to seasonality. Gross margins expanded by approximately 400 basis points year-over-year to nearly 28%. This boost in margins was supported by higher potato prices, including a 20% increase in prices in North America and a 35-40% increase in Europe. LW's management expressed positivity about the current operating environment, emphasizing the health of the global frozen potato category with balanced supply and demand dynamics. Additionally, consumer demand for fries at food service outlets in LW's key markets remained steady and above pre-pandemic levels. LW also noted that quick-service-restaurant traffic growth offset declines in full-service-restaurant channels, a trend influenced by inflation that has driven consumers toward more affordable quick-service venues. This shift is beneficial for QSR chains like McDonald's, Wendy's, and Restaurant Brands International, but could be challenging for full-service restaurant companies like Brinker International. LW expects upcoming potato crop harvests in North America and Europe to align with historical averages due to improved growing conditions in these regions. As a result of its solid Q1 performance and optimistic expectations for crop harvests, LW has raised its FY24 outlook. It now forecasts adjusted EPS in the range of $5.50 to $5.95, up from the previous range of $4.95 to $5.40, and revenue in the range of $6.8 billion to $7.0 billion, a $0.1 billion improvement. After a challenging Q4 (May) report that led to a decline in investor confidence, LW's Q1 results suggest that many of its difficulties may have been short-lived. Despite potential inflationary pressures, LW has already secured price hikes for around 80% of its contracts. With positive harvest expectations and improving traffic trends, Lamb Weston appears to be in the midst of a broader turnaround.

Previous update:

Exxon Mobil (XOM) has posted stronger profits for the third quarter, with an estimated operating profit of $5.2-$6.7 billion for its oil and gas business, thanks to high oil and natural gas prices during the period. This news aligns with analysts' expectations and is seen as a positive sign for the oil and gas sector as earnings season approaches. However, the optimism is dampened by a recent sharp decline in crude oil prices due to rising gasoline inventories and macroeconomic concerns. Despite a 10% increase in XOM shares since August, the company had a solid quarter, primarily driven by higher crude oil prices and strong refining margins. Nevertheless, the Chemicals business experienced a decline in operating profit due to contracting industry margins, indicating a mixed performance. Overall, while XOM benefited from higher energy prices in Q3, market observers are cautious as commodity prices decrease, suggesting a potentially challenging quarter ahead.

Lamb Weston (LW) has seen a turnaround following its positive Q1 (August) earnings results. The global potato producer, with McDonald's as its largest customer, reported earnings that exceeded bottom-line estimates by the widest margin in over five years. Despite an 8% decrease in volumes year-over-year, mainly attributed to exiting lower-priced, lower-margin businesses and ongoing inventory destocking, LW expects volumes to improve as the year progresses. In Q1, LW achieved an adjusted EPS of $1.63, a 117% increase year-over-year, and revenue grew by 48% to $1.67 billion, driven in large part by recent acquisitions, especially in its EMEA business. Gross margins expanded significantly despite the seasonality of Q1, with higher potato prices playing a role. LW is optimistic about the current operating climate, citing a healthy global frozen potato category with balanced supply and demand dynamics. Quick-service-restaurant (QSR) traffic growth has offset declines in full-service-restaurant channels, benefiting chains like McDonald's and Wendy's. However, this shift away from full-service chains could pose challenges for companies like Brinker International. LW also expressed confidence in upcoming potato crop harvests in North America and Europe, which has led to an upward revision of its FY24 outlook, with adjusted EPS expected to be $5.50-$5.95 and revenue of $6.8-$7.0 billion. Despite potential inflationary pressures, LW has already secured price hikes in the majority of its contracts, and with positive harvests and improving traffic trends, the company appears to be on a path to a broader turnaround following a challenging Q4 report earlier this year.

Constellation Brands (STZ) reported a robust Q2 performance primarily driven by its thriving beer business, which marked its largest EPS beat in nearly three years. Despite the challenging economic environment, STZ successfully implemented price hikes, particularly benefiting its Mexican beer brands, with Modelo leading the pack as the top share gainer and the #1 brand in the U.S. beer category. However, a less encouraging trend continues to overshadow STZ's outlook. In 2021, the company sold a significant portion of its mainstream and lower-priced wine brands to prioritize premium labels like Kim Crawford, The Prisoner Wine Company, and Meiomi. While this strategy was expected to enhance margins and reinvigorate sales in the struggling Wine & Spirits segment, the desired turnaround has yet to materialize. Q2 results reflected an 11% decline in organic net sales and an 80-basis-point decrease in the operating margin to 18.2%. Unfortunately, the near-term horizon does not seem promising for the Wine & Spirits segment, with STZ maintaining a flat sales forecast while raising EPS guidance to $12.00-$12.20 for FY24. This increase, however, falls short of the Q2 estimate beat, hinting at a potential lowering of expectations for the second half of 2024. Despite the strong performance of the beer portfolio, concerns linger over STZ's future growth when the momentum for Modelo eventually wanes, and the Wine & Spirits segment continues to struggle. In summary, STZ had a solid quarter driven by its beer business, but the underperforming Wine & Spirits segment remains a lingering concern for the company's prospects.

Clorox (CLX) has experienced a significant decline in its stock value today due to the release of weak guidance for the first quarter of fiscal year 2024 (ending in September). The consumer products giant, known for its diverse range of brands such as Brita, Fresh Step, Glad, Liquid-Plumr, and Pine-Sol, had previously disclosed a cyberattack that was expected to have a substantial impact on its Q1 financial results. The recent guidance revealed the extent of the damage, which was quite surprising. Clorox anticipates a revenue decline of 23-28%, equivalent to $1.25-1.34 billion, considerably below analyst expectations. Organic sales are projected to decrease by 21-26%, a significant deviation from prior guidance that suggested mid-single-digit growth. Particularly noteworthy is the adjusted EPS guidance for Q1, which stands at $(0.40)-0.00, falling even further below analyst projections. Clorox detailed that the cyberattack had caused widespread disruptions in its operations, leading to delays in order processing and significant product shortages. Prior to the cyberattack, shipment and consumption trends were on track with expectations. Furthermore, the gross margin is expected to decline year-over-year due to the cybersecurity attack outweighing the benefits of pricing, cost savings, and supply chain optimizations. Despite these challenges, there is some optimism for the future. Clorox anticipates that the operational impacts will continue to diminish in Q2 (December) as it progresses towards normalized operations. Additionally, the company expects to benefit from the replenishment of retailer inventories as it ramps up fulfillment during Q2. Clorox is currently evaluating the overall impact on fiscal year 2024 and will provide updated guidance during its upcoming earnings call next month. In terms of stock performance, it appears that investors were already prepared for weak guidance for the September quarter. The company's transparency in addressing the situation and providing updates has been acknowledged. Although the situation appears challenging at the moment, similar cases in the past, such as Chipotle and Boeing, have seen resolutions and subsequent recoveries. While the trajectory of Clorox's stock remains uncertain, the issue is expected to be resolved over time. Moreover, with retailers restocking their inventories, there may be potential for improved results in the near future. The stock has experienced a significant pullback since mid-August, and its decline has pushed the dividend yield to nearly 4%. Given these factors, Clorox may be worth monitoring closely.

Conagra (CAG) saw its shares dip to 52-week lows following its Q1 (August) results, which included a slight sales miss and a reiteration of its FY24 (May) guidance. The consumer-packaged-goods company, known for brands like Slim Jim and Vlasic, did manage to exceed earnings expectations, marking its sixth consecutive earnings beat. While volumes began to show signs of improvement in the four-week period ending August 26, the company, along with peers such as SJM, CPB, K, GIS, and POST, may be in the early stages of a turnaround. However, revenue remained flat year-over-year at $2.9 billion, despite a 6.3% price increase, as consumer behavior continued to be unfavorable, resisting price hikes and reducing their purchases. This resulted in a 6.6% decline in volumes on an organic basis, marking the 11th consecutive quarter of year-over-year declines. Among Conagra's segments, Refrigerated & Frozen experienced a 4.6% drop in revenue to $1.2 billion, accompanied by a 10.5% decrease in volumes. Meanwhile, Grocery & Snacks saw a modest 1.2% increase in revenue to $1.2 billion, driven by a 5.6% price increase. The Foodservice segment grew by 5.2% to $289 million, aided by a 10.3% price increase. The star performer was the International segment, with an 11.4% increase in sales to $260 million, despite prices rising by 7.9%, and a slight volume improvement of 0.3%. Conagra's main challenge hasn't been solely the shift to private labels, although it has played a role. Instead, it's the result of consumers tightening their spending habits and causing a slowdown across various categories. On a positive note, Conagra managed to expand its adjusted operating margins in Q1, achieving a 300 basis point improvement year-over-year to 16.7%, returning to pre-pandemic levels. Consequently, adjusted EPS saw a solid 15.8% increase to $0.66, surpassing estimates by a larger margin compared to Q4 (May). However, much of the margin expansion was driven by price increases, which could pose problems, as Conagra has limited room to reduce prices to compete in a slowing demand environment without impacting its margins. Conagra also mentioned that it doesn't expect the Q1 adjusted operating margins to persist and reiterated its forecast of 16.0-16.5% for FY24, citing additional trade and advertising and promotional spending. Despite ongoing shifts in consumer behavior weighing on Conagra's quarterly performance, the company's consistent earnings beats and reiteration of guidance in a challenging macroeconomic environment are seen as positive signs. Most of Conagra's challenges may already be reflected in its stock price, which is trading around March 2020 levels. As comparisons become more favorable in the latter part of the year, current price levels could be appealing to long-term investors.

Previous update:

In the wake of RPM Inc's (RPM) Q1 results for August, which exceeded expectations, the company's stock saw a 6% increase, attributed to the success of its MAP 2025 initiatives that have bolstered margins and led to an impressive 11.5% year-over-year jump in Q1 earnings per share (EPS) to $1.64. RPM also reported record Q1 revenue of $2.01 billion, up 4.1% from the previous year. The CEO, Frank Sullivan, characterized the current economic climate as "mixed," citing varying performances across different geographies. While some regions, like Africa, the Middle East, and Latin America, displayed resilience, Europe remained relatively weak but showed signs of returning to positive year-over-year growth. North American demand remained moderate, with RPM lapping unfavorable comparisons from the previous year in the region. Despite the mixed economic landscape, all RPM segments, except for Specialty Products Group, posted year-over-year sales growth in Q1. The standout performer was the Construction Products Group, which achieved record sales of $783 million, driven by strength in roofing, facades, and parking structures. However, in Specialty Products, OEM demand was subdued, particularly in the residential sector, leading to RPM maintaining a conservative outlook for FY24. Nevertheless, the company's MAP 2025 initiatives are expected to provide tailwinds, and declining inflationary pressures are anticipated to make the second half of the year less challenging.

Intel Corporation (INTC) has taken a significant step in its transformation journey by announcing its intention to separate its Programmable Solutions Group (PSG) into a standalone business through an IPO. This strategic move aims to streamline Intel's operations and focus on core businesses while raising capital for constructing new factories. The IPO is expected to take place in the next two or three years, potentially unlocking value for the PSG business and enhancing Intel's competitiveness in its Client Computing Group (CCG) and Data Center and AI Group (DCAI) segments. INTC had previously executed a similar spin-off of autonomous driving technology company Mobileye (MBLY) through an IPO, resulting in positive stock performance for both companies. CEO Pat Gelsinger acknowledged that PSG's performance had been suboptimal due to a lack of focus on various markets, and the standalone PSG is expected to capitalize on growth opportunities more effectively. By maintaining a majority stake in PSG post-IPO, INTC can benefit from its growth while using the proceeds to expand its U.S. manufacturing capacity. The move allows Intel to allocate more resources to strengthen its core CCG and DCAI operations, bridging the competitive and technological gap and enhancing its AI capabilities to compete with NVIDIA (NVDA) and Advanced Micro Devices (AMD). This spin-off represents a pivotal step in INTC's transformation as it progresses with its chip manufacturing expansion plans, potentially accelerating its overall progress.

Helen of Troy (HELE) reported its Q2 (August) results, which initially appeared solid as they exceeded earnings and sales estimates. However, the company's slimmer earnings per share (EPS) beat compared to the previous quarter, narrowed revenue guidance for FY24, and ongoing macroeconomic uncertainties caused a notable 8% decline in its stock. HELE, known for owning brands like OXO and Vicks, has been engaged in a company-wide restructuring named "Project Pegasus" this year, which has aided its bottom line amid declining discretionary spending. Unfortunately, this initiative did not offset macroeconomic headwinds as effectively as it did in Q1 (May), contributing to the current sell-off. Furthermore, weak demand persisted in Q2, with HELE's top line declining by 5.7% year-over-year to $491.6 million. Although revenue surpassed analyst expectations, it did not result in an improved FY24 sales outlook. Instead, HELE reduced the upper end of its revenue prediction by $5.0 million, now expecting revenues between $1.965 billion and $2.015 billion, narrowed from the previous range of $1.960 billion to $2.020 billion. Each of HELE's segments experienced sales declines in the quarter, with Home & Outdoor slipping by 0.2% to $240.0 million and Beauty & Wellness falling by 10.4% to $251.6 million. In Home & Outdoor, stagnant growth resulted from lower insulated beverage sales and adverse impacts from the Bed, Bath & Beyond bankruptcy, partially offset by strong demand for travel-related products. In contrast, the Beauty & Wellness segment witnessed consumers delaying spending on appliances like heaters, fans, and humidification products, while retailers reduced inventory levels, keeping a lid on new orders. HELE's Q2 report noted improvements in gross and operating margins, with a 420 basis point increase in gross margin and a 50 basis point increase in operating margin year-over-year. However, these improvements were primarily attributed to lower freight costs, the absence of EPA compliance costs, and reduced inventory obsolescence expenses. Despite exceeding estimates, EPS of $1.74 represented a 23.3% decline year-over-year, reflecting the challenging economic landscape. Management anticipates a slower economy and pressure on consumer spending, maintaining its focus on Project Pegasus, which is expected to yield $75-85 million in annualized pre-tax operating profit improvements by the end of FY26 (February). Encouragingly, HELE reiterated its FY24 EPS outlook of $8.50 to $9.00, despite the lackluster demand backdrop.

Acuity Brands (AYI) ended FY23 on a strong note with a robust earnings per share (EPS) beat in its Q4 (August) report, leading to a 4% increase in its stock. While revenue declined 9% year-over-year to $1.01 billion, which was generally in line with expectations or slightly missed, AYI provided upbeat EPS guidance for FY24. This guidance, with a mid-point above analyst expectations, suggests that the strong EPS performance is likely to continue. AYI expects its ABL segment to have low to mid-single-digit sales declines due to lighting macro environment conditions. On the other hand, the ISG segment is projected to grow in the mid-teens, driven by market share expansion and geographic expansion. AYI's ABL segment saw retail as the only channel with year-over-year growth, growing by 6% to $46.6 million. However, the Independent sales network, the largest channel by far, experienced an 8.3% year-over-year decline to $676 million. AYI attributes this decline to reduced purchases of lighting and lighting control products by customers. Market conditions in lighting are expected to remain similar for the rest of the calendar year, with the potential for some improvement in the following year. AYI reported a large backlog at the beginning of FY23, which has since reduced due to compressed lead times and destocking. AYI's margins improved, with adjusted operating margin increasing to 16.1% from 15.3% year-over-year, despite the 9% decline in revenue. This improvement is attributed to AYI's focus on higher-margin sales and a product portfolio refresh, which introduced many new product families. While FY23 was a challenging year for lighting products, AYI's strong Q4 EPS beat, robust FY24 EPS guidance, and positive commentary on the call have driven its stock higher. The focus on higher-margin sales, even if impacting the top line, is delivering improved margins and EPS upside. AYI also hinted at the potential for lighting improvement in calendar 2024, offering hope amid recent negativity surrounding the company.

Previous update:

Airbnb's (ABNB) stock is heading towards its lowest point in August as it received a downgrade from KeyBanc, dropping by 5% in today's trading session. This downgrade, from "Overweight" to "Sector Weight," marks the second instance this year of an analyst revising their rating downward. After a challenging 2022 that saw a 50% drop in Airbnb's shares, the company had been on a more positive trajectory in 2023, with a year-to-date increase of over 50%. However, there are potential challenges on the horizon that could hinder its future growth, particularly competition from hotel chains, rising service fees, and regulatory hurdles. Hotel chains like Marriott and Hilton offer better privacy and accommodations compared to Airbnb, and they do not face the same costs as Airbnb hosts, potentially limiting Airbnb's supply and increasing prices for customers. Additionally, companies like Expedia and Booking Holdings have been expanding their alternative accommodation portfolios, posing further competition for Airbnb. Regulatory issues may persist as Airbnb continues to expand both in the U.S. and overseas. All of these factors could impact Airbnb's growth if inflationary pressures persist, leading travelers to opt for cheaper hotel options.

ODDITY Tech (ODD), an online beauty and wellness company, experienced a promising IPO in July, but its stock price fell significantly afterward. However, it recently raised its Q3 revenue growth forecast, indicating renewed optimism. Notably, the magnitude of this increase is impressive, given the current slowdown in discretionary spending. Competitor Ulta Beauty took a cautious stance on the demand outlook in its recent earnings report, making ODDITY Tech's bullish view stand out. ODDITY Tech's tech-driven approach, using machine learning and AI to capture customer data, has disrupted the makeup and beauty industry. Approximately 80% of the $600 billion global beauty and wellness market is offline, making ODDITY Tech's digital-based strategy influential. The company's brands, IL MAKIAGE and SpoiledChild, have seen rapid growth, with IL MAKIAGE projected to generate nearly $500 million in revenue this fiscal year. ODDITY Tech is also profitable, with improving margins, and it raised its Q3 gross margin and adjusted EBITDA guidance. This indicates that ODDITY Tech's tech-driven approach is making waves in a challenging business environment with slowing discretionary spending.

McCormick's (MKC) Q3 earnings report has disappointed investors, as the spice and condiment supplier's earnings per share (EPS) were in line with expectations, and revenue missed slightly. Despite this, McCormick did raise its FY23 EPS guidance by $0.02, which suggests some upside in Q4. This quarter was significant as it included the summer grilling season and marked the start of Brendan Foley's tenure as the new CEO, although his challenges began after the quarter ended. McCormick cited a slower economic recovery in China, the divestiture of Kitchen Basics, exiting the Consumer business in Russia, and strategic decisions to discontinue low-margin business as reasons for its performance. McCormick's two segments, Consumer and Flavor Solutions, were affected differently, with Consumer sales increasing by 1%, impacted by pricing increases offset by lower volume, and Flavor Solutions segment sales rising by 12%, driven by pricing actions and volume growth. Investors are disappointed, given the stock's recent decline, and are concerned about the slow recovery in China and Consumer segment growth.

Eli Lilly's (LLY) announcement of its $1.4 billion acquisition of POINT Biopharma has led to a negative market reaction, with its shares declining. The premium paid for POINT Biopharma has caused its shares to surge towards the acquisition price. POINT Biopharma is a pharmaceutical company with preclinical-stage radioligand therapies for cancer treatment. Eli Lilly's stock had been performing well this year, driven by positive developments, particularly the potential approval of its type 2 diabetes treatment, Mounjaro, for weight loss. However, the acquisition's impact on its stock is likely minimal, and concerns may be related to the high valuation, especially regarding the potential for weight-loss drugs. Eli Lilly's forward earnings multiple has risen significantly, reflecting excitement around Mounjaro. Weight-loss drugs face headwinds such as patient considerations and competition from surgical treatments. Additionally, uncertainties surround Eli Lilly's Alzheimer's disease treatment, donanemab, which is awaiting FDA action.

Previous update:

Tesla's (TSLA) Q3 production saw a decline of nearly 8% compared to the previous quarter, down to 430,488 vehicles, falling short of analysts' expectations. However, this drop was somewhat anticipated due to planned factory downtimes in Tesla's Shanghai facility as part of preparations for the Model 3 refresh. Market reactions have been relatively muted as this decline doesn't appear to be driven by a drop in demand. Notably, Tesla has maintained its 2023 volume target of 1.8 million vehicles. Still, there are concerns about a potential delay in the long-awaited Cybertruck launch, which was initially scheduled for 2021 and later expected in Q3 but has not materialized. Given that the Cybertruck is seen as a significant growth catalyst, further delays could negatively impact production and earnings estimates for 2024. Additionally, rising interest rates and economic concerns in China raise questions about Tesla's increasing inventories, possibly indicating an attempt to manage them by producing fewer vehicles.

Meanwhile, Toast (TOST), a digital technology platform for the restaurant industry, received a downgrade from Mizuho, shifting from a "Buy" to a "Neutral" rating. While the stock initially saw losses, it eventually recovered some ground. This downgrade stands out as one of the few bearish sentiments surrounding Toast in recent months, primarily because the company has shown resilience and strong performance, even after facing challenges in FY22. Toast has been delivering solid financial figures, raised its FY23 guidance, and has a promising incoming CEO, Aman Narang, who has been with the company for a significant period. Toast's expansion into the hotel industry through a partnership with Marriott demonstrates its ability to grow beyond small businesses and enhance its enterprise segment. While Toast Capital faced some headwinds in Q2, it still holds potential in the restaurant industry. Despite the short-term challenges and the downgrade, Toast's long-term prospects remain positive, particularly with the ongoing digital transformation in the restaurant sector and potential overseas expansion opportunities.

Rivian Automotive (RIVN) has reported better-than-expected Q3 production figures but also faced negative attention in the financial media, particularly from the Wall Street Journal. The article highlighted RIVN's high production costs and complex assembly, revealing that the company is losing over $30,000 on every vehicle it sells. While RIVN has been narrowing its losses through cost-cutting, it is still burning through over $1.0 billion in cash per quarter. Achieving a gross profit by year-end, a milestone RIVN aims for, will require simultaneous expense reduction, production scaling, and potentially higher vehicle prices—a challenging endeavor. Nevertheless, some analysts, such as Evercore ISI and Robert W. Baird, see potential in RIVN due to improved production, cost benefits from a better supply chain, and more in-house components. RIVN's Q3 production reached 16,304 vehicles, surpassing expectations and increasing by 23% compared to the previous quarter. The company has reaffirmed its annual production forecast of 52,000 vehicles. While RIVN's path to profitability is promising, it remains uncertain, particularly with the backdrop of higher interest rates and potential macroeconomic fluctuations.

On this Spinoff Monday at the start of Q4, several companies are spinning off business segments into new independently traded entities. Kellogg (K) is perhaps the most notable, separating its snacks and cereal segments into two independently traded companies: Kellanova (snacks) and WK Kellogg (cereal). The move is aimed at recognizing the different growth rates and characteristics of these segments, potentially garnering a higher multiple for the faster-growing snacks business. Meanwhile, Danaher (DHR) is spinning off Veralto (VLTO), its environmental-and-applied solutions segment, and Aramark (ARMK) is spinning off Vestis (VSTS), its uniform rental services business, to focus on food and facilities management. These spinoffs align with strategic decisions to unlock value and streamline operations within these companies.

ZoomInfo (ZI) has reconfirmed its FY23 outlook, but this move hasn't provided a significant boost to its struggling stock. The company's reiterated FY23 adjusted earnings per share (EPS) and revenue forecasts of $0.99-1.00 and $1.225-1.235 billion, respectively, don't offer much excitement, especially considering that these estimates were previously revised downward in late July. Additionally, as part of its broader turnaround plan, ZoomInfo announced organizational changes, including the transition of its COO Joseph Hays to the role of Executive VP of International Expansion. The company's shares have experienced a series of gap-downs since reaching all-time highs in November 2021. One of the main factors contributing to ZI's stock struggles, typical for a software-based firm catering to sales teams, is the impact of rising interest rates on growth prospects and valuations. ZI's forward earnings multiple, which was over 100x at its peak two years ago, has now dropped to 16x. ZoomInfo has been taking steps to streamline its organization throughout the year, including a 3% reduction in its workforce starting in June, in an effort to improve efficiency. However, its growth has decelerated significantly, dropping from +45.5% in 3Q22 to +15.5% in Q2. Given this slowdown and the shift of customers from growth to profitability, ZI may announce further cost-saving measures. This customer behavior was a significant factor in the disappointing Q2 report in late July. Interestingly, despite facing similar headwinds, competitors like Salesforce (CRM) and HubSpot (HUBS) have managed to perform better, with CRM issuing strong FY24 guidance and HUBS raising its FY23 financial goals. ZI's focus on improving profitability in FY23 anticipates only a modest 12% year-over-year improvement, a considerable drop from the 53% increase in FY22. Nevertheless, ZI aims to maintain at least 40% adjusted operating margins despite lower-than-expected revenue, thanks to its streamlining efforts offsetting economic challenges. As a software provider primarily serving other software firms' sales efforts, ZI faces a particularly tough year compared to some rivals. Elevated interest rates are likely to continue constraining customer spending, making it difficult for ZI to stage a turnaround without aggressive cost-cutting or a significant demand upturn.